Globus Medical

Globus Medical

Price: 80.86

Company and Business Model

Globus Medical is a healthcare company specializing in musculoskeletal solutions. Its core products include spinal implants, surgical instruments, and biologics aimed at improving patient outcomes in spinal surgery. The company operates primarily in the spinal surgery segment, with major revenue sources stemming from the sale of its innovative surgical devices and related services.

Investment Profile

The investment profile of Globus Medical is more aligned with balanced investors, given its focus on innovation and market presence while facing some volatility. The company has potential for growth, but current revenue trends suggest caution. This profile may appeal to those looking for a mix of stability and growth opportunities.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
4.35 OK
Revenue QoQ — quarter-over-quarter revenue growth
-8.1%
EPS surprise
21.7% better than expected
20d volatility
2.0% stable
FMP / FinFeed data updated: 2026-06-09
Reco: Sell Potential: 47 Risk: 66 Updated: 2026-06-11 05:20
How recommendation works
Why AI thinks so:
Weak fundamentals and mixed momentum signal caution.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-06-09 02:41 Hold Sell Weak fundamentals and negative momentum indicate high risk.
2026-06-01 02:39 Sell Hold Weak fundamentals and negative momentum signal high risk.
2026-05-22 02:46 Hold Sell Weak fundamentals and negative momentum raise concerns.
Analyst forecasts
Date Analyst Action Target Price Then
2026-05-08 13:46 Needham Target Raised 114 → 117 78.765
2026-05-08 11:47 Wells Fargo Target Lowered 104 → 103 85.08
2026-02-25 14:37 Truist Financial Target Raised 105 → 115 94.32